Multi‐Omics Reveals a Cryptic RNF213::SLC26A11 Fusion and Targeted Therapy Dynamics in a Patient With Refractory Leukemia

The authors declare no conflicts of interest. The original raw sequencing datasets (FASTQ files) generated and analyzed during the current study are not publicly available due to strict patient privacy protection and institutional ethical regulations regarding human genetic resources. However, the processed genomic and transcriptomic data supporting the conclusions of this article (including specific variant lists, allele frequencies, and structural variant validations) are included within the article and its supplementary information. Further deidentified data are available from the corresponding author upon reasonable academic request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
Pediatric Blood & Cancer
Published
2026-10-19
DOI
https://doi.org/10.1002/1545-5017.70777
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi‐Omics Reveals a Cryptic RNF213::SLC26A11 Fusion and Targeted Therapy Dynamics in a Patient With Refractory Leukemia

张明瑛, Zhigang Li, Wu Ying, Peijing Qi et al.
Pediatric Blood & Cancer
Acute Myeloid Leukemia Research
article

Multi‐Omics Reveals a Cryptic RNF213::SLC26A11 Fusion and Targeted Therapy Dynamics in a Patient With Refractory Leukemia

张明瑛, Zhigang Li, Wu Ying, Peijing Qi, Jinlei Yin, Ruidong Zhang, Wei Lin, Yuanyuan Zhang, Jia Fan
article en

Abstract

The authors declare no conflicts of interest. The original raw sequencing datasets (FASTQ files) generated and analyzed during the current study are not publicly available due to strict patient privacy protection and institutional ethical regulations regarding human genetic resources. However, the processed genomic and transcriptomic data supporting the conclusions of this article (including specific variant lists, allele frequencies, and structural variant validations) are included within the article and its supplementary information. Further deidentified data are available from the corresponding author upon reasonable academic request. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Pediatric Blood & Cancer
Capital Medical University (CN), Beijing Children’s Hospital (CN)
Openalex Percentile: Top 12%
Acute Myeloid Leukemia Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Multi‐Omics Reveals a Cryptic RNF213::SLC26A11 Fusion and Targeted Therapy Dynamics in a Patient With Refractory Leukemia — 张明瑛, Zhigang Li, et al. · Pediatric Blood & Cancer (2026) | TGRS Research Map | TGRS